MORGAN STANLEY

Holdings History for Immunome Inc. - Common Stock, $0.0001 par value per share (IMNM)

Symbol: IMNM on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$36,711,252	1,709,089	-124,729	-6.8%	$21.48	Q4 2025
30 Sep 2025	0%	+0%	$21,474,020	1,833,818	+1,429,461	+354%	$11.71	Q3 2025
30 Jun 2025	0%	-0%	$3,760,528	404,357	-459,866	-53%	$9.30	Q2 2025
31 Mar 2025	0%	+0%	$5,816,221	864,223	+465,357	+100%	$6.73	Q1 2025
31 Dec 2024	0%	+0%	$4,235,958	398,866	+109,788		$10.62	Q4 2024
31 Dec 2024		0%	$19	1	0		$19.00 ^*	Q4 2024
30 Sep 2024	0%	-0%	$4,226,325	289,078	-82,880		$14.62	Q3 2024
30 Jun 2024	0%	+0%	$4,500,691	371,958	+222,561	+100%	$12.10	Q2 2024
31 Mar 2024	0%	+0%	$3,687,118	149,397	+137,242	+1129%	$24.68	Q1 2024
31 Dec 2023	0%	0%	$130,058	12,155	0		$10.70	Q4 2023
30 Sep 2023	0%	-0%	$101,494	12,155	-1,311	-9.7%	$8.35	Q3 2023
30 Jun 2023	0%	+0%	$106,517	13,466	+1,336	+11%	$7.91	Q2 2023
31 Mar 2023	0%	0%	$60,528	12,130	0		$4.99	Q1 2023
31 Dec 2022	0%	0%	$26,807	12,130	0		$2.21	Q4 2022
30 Sep 2022	0%	0%	$53,000	12,130	-800	-6.2%	$4.37	Q3 2022
30 Jun 2022	0%	0%	$41,000	12,930	-802	-5.8%	$3.17	Q2 2022
31 Mar 2022	0%	-0%	$78,000	13,732	-64,939	-83%	$5.68	Q1 2022
31 Dec 2021		0%	$1,000	44	0		$22.73 ^*	Q4 2021
31 Dec 2021	0%	+0%	$1,019,000	78,671	+64,596	+459%	$12.95	Q4 2021
30 Sep 2021	0%	+0%	$343,000	14,075	+2,722	+24%	$24.37	Q3 2021
30 Jun 2021	0%	+0%	$196,000	11,353	+11,233	+9361%	$17.26	Q2 2021
31 Mar 2021	0%	-0%	$4,000	120	-2,128	-95%	$33.33	Q1 2021
31 Dec 2020	0%	+0%	$22,000	2,248	+2,248	NEW	$9.79	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.